Steve Tutewohl is COO at Evolent Health, Inc. (EVH). They have made 8 open-market trades across 1 company since 2021, most recently 2023-07-01.
CIK 0001811845
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 8 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| EVH | 136,331 | $654K |
Shares reported on the most recent Form 4, priced at the 2024-04-26 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| EVH | SELL | 2022-03-03 | 2022-03-07 | $27.30 | $105K | +9.5% | +6.8% | +7.2% |
| EVH | SELL | 2022-03-01 | 2022-03-03 | $27.41 | $295K | +6.0% | +14.8% | +4.5% |
| EVH | SELL · 10b5-1 | 2022-02-03 | 2022-02-07 | $22.85 | $39K | +3.7% | +32.0% | +16.5% |
| EVH | SELL | 2022-02-01 | 2022-02-01 | $23.47 | $296K | -0.0% | +14.0% | +19.4% |
| EVH | SELL | 2021-09-01 | 2021-09-02 | $25.05 | $679K | +4.2% | +28.7% | +0.2% |
| EVH | SELL | 2021-08-02 | 2021-08-04 | $23.02 | $1.4M | +2.4% | +15.0% | +28.9% |
| EVH | SELL | 2021-07-09 | 2021-07-13 | $22.58 | $552K | -2.6% | +8.4% | +48.5% |
| EVH | SELL · 10b5-1 | 2021-07-08 | 2021-07-12 | $22.00 | $4K | -4.3% | +6.9% | +47.7% |
| EVH | SELL | 2021-07-01 | 2021-07-02 | $21.05 | $394K | +6.5% | +8.3% | +48.3% |
| EVH | SELL | 2021-05-03 | 2021-05-05 | $21.48 | $829K | -7.0% | -13.1% | +8.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.